Home > Insider Trading > Filing (0001140361-15-037180)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1472091	Edge Therapeutics Inc.	EDGE	Pharmaceutical Preparations (2834)	264231384

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1196054	Ii N Albert Marchio	200 Connell Drive, Suite 1600 Berkeley Heights NJ 07922	Chief Acct. & Op., Asst. Sec.	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-10-06	5,504	$0.00	5,504	No	4	C	Direct
Common Stock	Acquisiton	2015-10-06	100	$11.00	6,504	No	4	P	Direct
Common Stock	Acquisiton	2015-10-06	357	$7.24	6,861	No	4	J	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	P	Direct
No	4	J	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series C-1 Convertible Preferred Stock	Disposition	2015-10-06	7,530	$0.00	5,504	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

The convertible preferred stock converted into the Issuer's common stock at a conversion ratio, as adjusted to give effect to the Issuer's 1-for-1.3681 reverse stock split effected on September 21, 2015, of one share of common stock for every 1.3681 shares of preferred stock immediately prior to the closing of the Issuer's initial public offering of common stock, and had no expiration date.
The Reporting Person received a total of 357 shares of the Issuer's common stock which represented a payment-in-kind dividend on 7,530 shares of the Issuer's convertible preferred stock owned at the time of the dividend payment date.